Pregnancy-Onset Ulcerative Colitis in a Pediatric Patient Presenting With Altered Mental Status and Severe Anemia

Alda Huang1, Gregory L Stone2, Brian Gordon3

  • 1Department of Combined Internal Medicine and Pediatrics, Los Angeles County University of Southern California Medical Center, Los Angeles, USA.

Cureus
|August 2, 2022
PubMed

Insights

A rare case of ulcerative colitis (UC) in a pregnant teen highlights diagnostic challenges. Early diagnosis and treatment of pregnancy-onset inflammatory bowel disease (IBD) are crucial for positive outcomes.

Area of Science:

  • Gastroenterology
  • Maternal-Fetal Medicine
  • Pediatric Gastroenterology

Background:

  • Ulcerative colitis (UC) typically presents with gastrointestinal symptoms but can manifest atypically in specific populations.
  • Pediatric and pregnant patients may present unique diagnostic challenges for UC.
  • Inflammatory bowel disease (IBD) diagnosis during pregnancy requires careful consideration.

Observation:

  • A 16-year-old primigravida at 18 weeks gestation presented with altered mental status and severe anemia.
  • Hematochezia developed post-admission, prompting an extensive diagnostic workup.
  • The patient was diagnosed with UC via endoscopic and histopathologic examination.

Findings:

  • High-dose steroids and infliximab induced prenatal remission of UC.
  • The pregnancy was complicated by severe preeclampsia.
  • The infant experienced a medically complex post-delivery course due to unrelated factors.

Implications:

  • Pregnancy-onset IBD in adolescents is uncommon yet clinically significant.
  • Prompt diagnosis, tailored treatment, and comprehensive counseling are essential.
  • Effective management can lead to outcomes comparable to non-IBD patients.

Related Concept Videos

Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
301
Drugs for Treatment of Ulcerative Colitis in IBD01:29

Drugs for Treatment of Ulcerative Colitis in IBD

Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
229
Peptic Ulcer Disease I: Introduction01:30

Peptic Ulcer Disease I: Introduction

Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
273
Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents01:24

Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents

In the intricate landscape of the gastric lumen, excessive acid secretion disrupts the natural defense mechanisms, weakening the mucus-bicarbonate barrier. This vulnerability allows pepsin to infiltrate epithelial cells, digesting mucosal proteins and triggering erosion, leading to ulcer formation.
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
669
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
401
Peptic Ulcer Disease IV: Management01:26

Peptic Ulcer Disease IV: Management

Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
139